16 Oct 2020 --- Lonza has established a new structure and culture for its businesses. The company now has a dedicated focus on the pharma and biotech industry, and has introduced a structural and cultural blueprint set to create a harmonized “one business” identity. This will also provide a greater level of transparency on company performance to Lonza’s investor and analyst community.
